Hi everyone,
We've just published the first two videos in a four part series featuring Lee Thomas and our CEO, Dr Philippe Wolgen, discussing the company's vitiligo program with the drug SCENESSE® (afamelanotide). You can view these on our website:
SCENESSE® and its use in vitiligo – Lee Thomas and Dr Philippe Wolgen, Part 1
Vitiligo trials of SCENESSE® – Lee Thomas and Dr Philippe Wolgen, Part 2
Parts 3 & 4 will be online in the next couple of weeks.
As always, I'm happy to answer any questions you may have about our program.
Lachlan
Replies